Stock Market Most Active AMEX Stocks Wednesday, December 11,

New Post Public Reply Private Reply Replies (0) Message Board
Polgar
AMEX Most Active 

SYMBOL NAME PRICE ($) CHANGE % CHANGE VOLUME
SPY SPDR S&P 500 179.59 -1.16 -0.64%  44,443,630
EEM iShares MSCI Emerging Index Fund 41.39 -0.63 -1.50%  28,143,105
IWM iShares Russell 2000 ETF 110.08 -1.35 -1.21%  18,731,569
FXI iShares FTSE China 25 Index Fund 38.67 -1.16 -2.91%  17,962,059
XLF SPDR Select Sector Fund - Financial 21.18 -0.22 -1.03%  17,870,576
VXX iPath S&P 500 VIX Short-Term Futures ETN 46.45 +1.45 +3.22%  14,768,541
GDX Market Vectors Gold Miners ETF 21.87 -0.16 -0.73%  11,349,316
EWJ iShares MSCI Japan Index Fund 11.88 -0.08 -0.69%  8,697,197
RNN Rexahn Pharmaceuticals Inc 0.47 +0.07 +18.41%  8,226,091
VWO Vanguard FTSE Emerging Markets ETF 40.78 -0.65 -1.56%  8,132,394
XLP SPDR Select Sector Fund - Consumer Staples 43.09 +0.23 +0.54%  7,927,993
TZA DIREXION DLY SM CAP BEAR 3X 19.94 +0.68 +3.53%  7,119,773
UVXY ProShares Trust Ultra VIX Short Term Futures ETF 20.14 +1.24 +6.56%  6,934,246
EWZ iShares MSCI Brazil Capped Index Fund 44.72 -0.95 -2.08%  6,075,008
XLE SPDR Select Sector Fund - Energy Select Sector 85.60 -0.68 -0.78%  5,681,713
GLD SPDR Gold Trust 121.49 -0.33 -0.27%  5,319,635
TNA Direxion Small Cap Bull 3x Shares 67.91 -2.53 -3.59%  4,607,913
IYR iShares U.S. Real Estate ETF 62.94 -0.87 -1.36%  4,191,845
EFA iShares MSCI EAFE ETF 64.83 -0.36 -0.55%  4,040,706
XLI SPDR Select Sector Fund - Industrial 49.82 -0.54 -1.07%  3,737,348
SDS ProShares UltraShort S&P500 31.77 +0.43 +1.37%  3,630,382
XLU SPDR Select Sector Fund - Utilities 37.68 -0.15 -0.40%  3,423,669
SSO ProShares Ultra S&P500 96.15 -1.23 -1.26%  3,365,627
DIA SPDR Dow Jones Industrial Average ETF 158.91 -0.81 -0.51%  3,178,850
USO United States Oil Fund 35.06 -0.25 -0.71%  3,088,640
TLT iShares 20 Year Treasury Bond ETF 103.65 -0.25 -0.24%  2,804,246
NUGT Direxion Daily Gold Miners Bull 3X Shares 30.10 -0.49 -1.60%  2,616,047
AGG iShares Core Total U.S. Bond Market ETF 106.92 -0.01 -0.01%  2,599,360
FAZ Direxion Financial Bear 3X Shares 24.11 +0.59 +2.51%  2,596,672
PSP PowerShares Listed Private Equity 12.28 -0.02 -0.15%  2,550,310
DXJ WisdomTree Japan Hedged Equity Fund 49.36 -0.52 -1.04%  2,432,534
NGD New Gold Inc. 5.26 +0.12 +2.33%  2,324,149
EPI WisdomTree India Earnings Fund 17.17 -0.39 -2.19%  2,321,054
XLV SPDR Select Sector Fund - Health Care 54.46 -0.65 -1.18%  2,282,568
SLV iShares Silver Trust 19.63 -0.03 -0.15%  2,262,692
FAS Direxion Financial Bull 3X Shares 81.36 -2.05 -2.45%  2,242,482
XLK SPDR Select Sector Fund - Technology 34.69 -0.17 -0.49%  2,189,295
ONVO Organovo Hldgs Inc 9.47 -0.58 -5.77%  2,150,076
SMH Market Vectors Semiconductor ETF 41.49 -0.18 -0.43%  2,052,199
IAU ishares Gold Trust 12.21 -0.04 -0.31%  1,980,084
RSX Market Vectors TR Russia ETF 28.07 -0.23 -0.81%  1,906,059
SPXU ProShares UltraPro Short S&P500 16.72 +0.31 +1.90%  1,835,465
EDC Direxion Emerging Markets Bull 3X Shares 27.30 -1.29 -4.51%  1,824,987
OIH Market Vectors Oil Services ETF 47.22 -0.28 -0.59%  1,824,931
PAL North American Palladium Ltd. 0.48 +0.01 +1.19%  1,783,760
XHB SPDR Series Trust SPDR Homebuilders ETF 30.87 -0.38 -1.22%  1,736,102
EWH iShares MSCI Hong Kong Index Fund 20.19 -0.44 -2.13%  1,731,890
XLB Materials Select Sector SPDR 44.09 -0.54 -1.21%  1,699,233
EWA iShares MSCI Australia Index Fund 24.19 -0.30 -1.24%  1,687,278
EWT iShares MSCI Taiwan Index Fund 14.32 -0.09 -0.62%  1,653,492
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading